| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3200471 | Journal of Allergy and Clinical Immunology | 2009 | 11 Pages |
Abstract
A drug combination directed against CRAC channels and leukotriene receptor antagonist suppresses the feed-forward loop that leads to aberrant mast cell activation. Hence our results identify a new potential strategy for combating polyposis and mast cell-dependent allergies.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Joseph BA, Charmaine BA, Grant BM, BCH, FRCS, Anant B. BM, BA, DPhil,